Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001628280-22-015910
Filing Date
2022-06-01
Accepted
2022-06-01 16:20:43
Documents
2
Period of Report
2022-06-01

Document Format Files

Seq Description Document Type Size
1 FORM 3 wf-form3_165411481588575.html 3  
1 FORM 3 wf-form3_165411481588575.xml 3 1680
2 CARROLL POA ex-24.htm EX-24 3966
  Complete submission text file 0001628280-22-015910.txt   7113
Mailing Address C/O CATALENT, INC. 14 SCHOOLHOUSE ROAD SOMERSET NJ 08873
Business Address
CARROLL J MARTIN (Reporting) CIK: 0001279901 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-35986 | Film No.: 22987607

Mailing Address 3891 RANCHERO DRIVE, SUITE 150 ANN ARBOR MI 48108
Business Address 3891 RANCHERO DRIVE, SUITE 150 ANN ARBOR MI 48108 734-887-3903
Esperion Therapeutics, Inc. (Issuer) CIK: 0001434868 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations